These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32621069)

  • 1. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
    Shirai Y; Miura K; Yabuuchi T; Nagasawa T; Ishizuka K; Takahashi K; Taneda S; Honda K; Yamaguchi Y; Suzuki H; Suzuki Y; Hattori M
    CEN Case Rep; 2020 Nov; 9(4):423-430. PubMed ID: 32621069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric IgA-Dominant Infection-Related Glomerulonephritis.
    Takagi Y; Kano Y; Oda T; Suzuki H; Ono Y; Yoshihara S
    Tohoku J Exp Med; 2024 Jun; 263(2):97-104. PubMed ID: 38355109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis.
    Zhang M; Zhou W; Liu S; Zhang L; Ni Z; Hao C
    Nephron; 2021; 145(3):225-237. PubMed ID: 33596564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report.
    Han W; Suzuki T; Watanabe S; Nakata M; Ichikawa D; Koike J; Oda T; Suzuki H; Suzuki Y; Shibagaki Y
    Medicine (Baltimore); 2021 Feb; 100(5):e24460. PubMed ID: 33592898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S; Horinouchi T; Fujimaru R; Shima Y; Kaito H; Tanaka R; Ishimori S; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Yamamura T; Yoshimura M; Nakanishi K; Fujimura J; Kamiyoshi N; Nagase H; Yoshikawa N; Iijima K; Nozu K
    Sci Rep; 2020 Aug; 10(1):14026. PubMed ID: 32820208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition.
    Tang X; Zheng J; Jiang X; Wan F; Hou X; Liu S; Zhang M; Song Y; Ye T; Yu J
    Int Urol Nephrol; 2023 Aug; 55(8):2119-2129. PubMed ID: 36849627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Immunosuppressive Therapy in the Treatment of IgA-dominant Infection-related Glomerulonephritis.
    Okumura M; Sugihara S; Seki K; Nagaoka K; Okawa N; Ebihara M; Inoue T; Fukuda J; Ohara M; Imasawa T; Kitamura H; Oda T; Suzuki T
    Intern Med; 2022; 61(5):697-701. PubMed ID: 35228476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinfectious glomerulonephritis secondary to Erythrovirus B19 (Parvovirus B19): case report and review of the literature.
    Marco H; Guermah I; Matas L; Hernández A; Navarro M; Lopez D; Bonet J
    Clin Nephrol; 2016 Apr; 85(4):238-44. PubMed ID: 26833301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjögren's syndrome: a case report.
    Nishioka R; Hara S; Kawahara H; Ito K; Mizushima I; Hirata M; Nagata M; Kawano M
    BMC Nephrol; 2021 Mar; 22(1):108. PubMed ID: 33765955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-infectious acute glomerulonephritis with podocytopathy induced by parvovirus B19 infection.
    Hara S; Hirata M; Ito K; Mizushima I; Fujii H; Yamada K; Nagata M; Kawano M
    Pathol Int; 2018 Mar; 68(3):190-195. PubMed ID: 29457859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.
    Handa T; Kakita H; Tateishi Y; Endo T; Suzuki H; Katayama T; Tsukamoto T; Muso E
    Clin Exp Nephrol; 2018 Oct; 22(5):1116-1127. PubMed ID: 29564665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy in teaching hospitals of Dhaka.
    Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
    Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy.
    Kauffmann M; Bobot M; Daniel L; Torrents J; Knefati Y; Moranne O; Burtey S; Zandotti C; Jourde-Chiche N
    BMC Nephrol; 2020 Jul; 21(1):260. PubMed ID: 32646497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
    Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.